Reviva Pharmaceuticals Holdings Past Earnings Performance
Past criteria checks 0/6
Key information
-62.3%
Earnings growth rate
-42.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | -686.5% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Here's Why Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) Must Use Its Cash Wisely
Aug 24
We're Keeping An Eye On Reviva Pharmaceuticals Holdings' (NASDAQ:RVPH) Cash Burn Rate
Dec 28Reviva Pharmaceuticals drops 9% on $8.5M private placement
Sep 06We're A Little Worried About Reviva Pharmaceuticals Holdings' (NASDAQ:RVPH) Cash Burn Rate
Aug 24Reviva Pharmaceuticals Q2 GAAP loss per share widens
Aug 15Reviva reports positive brilaroxazine results in Aacute Schizophrenia
Apr 26Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Reviva Pharmaceuticals Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -39 | 8 | 31 |
| 30 Sep 23 | 0 | -38 | 8 | 29 |
| 30 Jun 23 | 0 | -31 | 7 | 23 |
| 31 Mar 23 | 0 | -24 | 5 | 18 |
| 31 Dec 22 | 0 | -28 | 5 | 23 |
| 30 Sep 22 | 0 | -20 | 5 | 15 |
| 30 Jun 22 | 0 | -19 | 5 | 14 |
| 31 Mar 22 | 0 | -15 | 5 | 10 |
| 31 Dec 21 | 0 | -9 | 5 | 5 |
| 30 Sep 21 | 0 | -6 | 4 | 2 |
| 30 Jun 21 | 0 | -5 | 4 | 1 |
| 31 Mar 21 | 0 | -4 | 3 | 0 |
| 31 Dec 20 | 0 | -4 | 2 | 0 |
| 30 Sep 20 | 0 | -2 | 2 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -1 | 0 | 0 |
| 31 Dec 19 | 0 | -1 | 0 | 0 |
Quality Earnings: RVPH is currently unprofitable.
Growing Profit Margin: RVPH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RVPH is unprofitable, and losses have increased over the past 5 years at a rate of 62.3% per year.
Accelerating Growth: Unable to compare RVPH's earnings growth over the past year to its 5-year average as it is currently unprofitable